Changeflow GovPing Trade & Sanctions PTO Biological Materials Notice Public Comment
Routine Consultation Added Consultation

PTO Biological Materials Notice Public Comment

Favicon for www.regulations.gov Regs.gov: Patent and Trademark Office
Detected March 15th, 2026
Email

Summary

The Patent and Trademark Office (PTO) is accepting public comments on a notice regarding biological materials. The comment period is open for 24 days from the publication date.

What changed

The Patent and Trademark Office (PTO) is providing a public comment period for a notice concerning biological materials. This is a procedural step in the regulatory process, allowing interested parties to submit feedback on the notice.

Regulated entities, particularly those in the pharmaceutical and biotechnology sectors, should review the notice and consider submitting comments if they have relevant input. The comment period is short, ending 24 days after the notice's publication, so prompt action is advised for those wishing to participate.

What to do next

  1. Review the PTO biological materials notice.
  2. Submit comments to Regulations.gov within the 24-day comment period if applicable.

Source document (simplified)

Write a Comment

Commenter's Checklist
Public Comments on Federal Regulations

Comment *

5000

Attach Files

You can attach up to 20 files, but each file cannot exceed 10MB. Valid file types include: bmp, docx, gif, jpg, jpeg, pdf, png, pptx, rtf, sgml, tif, tiff, txt, wpd, xlsx, xml. Drop files here or Browse...

Email Address

Opt to receive email confirmation of submission and tracking number?
If you choose to identify as Anonymous, the option to receive an email confirmation will not be displayed. (We will never post the email address entered in the field above on Regulations.gov nor share it with anyone else.)

Tell us about yourself! I am... *

(Select an identity below)

An Individual

Yourself or another person whom
you represent with their consent

An Organization

A company, organization,
or government agency

Anonymous

A person who does not want their name
associated with the comment

Note: If you choose to identify as Anonymous, the option to enter your email address for submission confirmation is not available.

reCAPTCHA *

Solve with 2Captcha Do not submit personally identifiable information through this form. Any personally identifiable information (e.g., name, address, phone number) included in the comment form or in an attachment may be publicly disclosed in a docket or on the Internet (via Regulations.gov, a federal agency website, or a third-party, non-government website with access to publicly-disclosed data on Regulations.gov). By submitting a comment, you agree to the terms of participation and privacy notice.

Submit Comment

Please see the Privacy Notice and User Notice regarding comment submission.

Any information (e.g., personal or contact) you provide on this comment form or in an attachment may be publicly disclosed and searchable on the Internet and in a paper docket and will be provided to the Department or Agency issuing the notice. To view any additional information for submitting comments, such as anonymous or sensitive submissions, refer to the Privacy Notice and User Notice, the Federal Register notice on which you are commenting, and the Web site of the Department or Agency.

Classification

Agency
PTO
Instrument
Consultation
Legal weight
Non-binding
Stage
Consultation
Change scope
Minor

Who this affects

Applies to
Manufacturers Drug manufacturers Pharmaceutical companies
Geographic scope
National (US)

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Patents Biological Materials

Get Trade & Sanctions alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when Regs.gov: Patent and Trademark Office publishes new changes.

Free. Unsubscribe anytime.